Free Trial

ORIC Pharmaceuticals (ORIC) Earnings Date, Estimates & Call Transcripts

ORIC Pharmaceuticals logo
$8.33 +0.12 (+1.46%)
(As of 05:26 PM ET)

ORIC Pharmaceuticals Latest Earnings Summary

Actual EPS
(Nov. 12)
-$0.49 Missed By -$0.01
Consensus EPS
(Nov. 12)
-$0.48

ORIC Pharmaceuticals released Q3 2024 earnings on November 12, 2024, reporting an EPS of -$0.49, which missed the consensus estimate of -$0.48 by $0.01. With a trailing EPS of -$1.80, ORIC Pharmaceuticals' earnings are expected to decrease next year, from ($1.84) to ($2.13) per share.

Get ORIC Pharmaceuticals Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ORIC Pharmaceuticals and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

ORIC Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ORIC Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

ORIC Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242-$0.46-$0.43-$0.45
Q2 20242-$0.42-$0.41-$0.42
Q3 20242-$0.49$0.45-$0.02
Q4 20242-$0.51-$0.50-$0.51
FY 20248-$1.88-$0.89-$1.39
Q1 20252-$0.53-$0.47-$0.50
Q2 20252-$0.54-$0.49-$0.52
Q3 20252-$0.56-$0.51-$0.54
Q4 20252-$0.58-$0.52-$0.55
FY 20258($2.21)($1.99)($2.10)

ORIC Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/12/2024--$0.48-$0.49 -$0.01-$0.49--
8/12/2024Q2 2024-$0.42-$0.45 -$0.03-$0.45--
5/6/2024Q1 2024-$0.44-$0.37+$0.07-$0.37--
3/11/2024--$0.49-$0.49--$0.49--
11/6/2023Q3 2023-$0.46-$0.44+$0.02-$0.44--
8/10/2023Q2 2023-$0.58-$0.50+$0.08-$0.50--
5/8/2023Q1 2023-$0.54-$0.53+$0.01-$0.53--
3/16/2023Q4 2022-$0.56-$0.52+$0.04-$0.52--

ORIC Pharmaceuticals Earnings - Frequently Asked Questions

ORIC Pharmaceuticals (NASDAQ:ORIC) last announced its quarterly earning data on Tuesday, November 12, 2024. Learn more on ORIC's earnings history.

In the previous quarter, ORIC Pharmaceuticals (NASDAQ:ORIC) missed the analysts' consensus estimate of ($0.48) by $0.01 with a reported earnings per share (EPS) of ($0.49). Learn more on analysts' earnings estimate vs. ORIC's actual earnings.

ORIC Pharmaceuticals (NASDAQ:ORIC) has a recorded net income of -$100.70 million. ORIC has generated -$1.80 earnings per share over the last four quarters.

ORIC Pharmaceuticals's earnings are expected to decrease from ($1.84) per share to ($2.13) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:ORIC) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners